RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.8700
-0.0300 (-3.33%)
At close: Sep 1, 2026, 4:00 PM EDT
0.8500
-0.0200 (-2.30%)
After-hours: Sep 1, 2026, 7:56 PM EDT
RedHill Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.35 | 1.88 | 5.57 | 19.97 | 29.47 |
Short-Term Investments | 2.62 | 2.74 | - | 0.02 | 8.53 |
Cash & Short-Term Investments | 3.97 | 4.62 | 5.57 | 19.98 | 38 |
Cash Growth | -13.99% | -17.09% | -72.13% | -47.42% | 27.56% |
Accounts Receivable | 0.08 | 2.54 | 2.59 | 34.52 | 31.68 |
Other Receivables | 1.62 | 0.33 | 0.69 | 0.83 | 0.85 |
Receivables | 1.7 | 2.87 | 3.29 | 35.35 | 32.52 |
Inventory | - | 3.65 | 4.39 | 11.01 | 14.81 |
Prepaid Expenses | 0.78 | 0.69 | 0.8 | 2.52 | 3.18 |
Restricted Cash | - | - | 0.79 | 16 | - |
Other Current Assets | 0.08 | 0.08 | 1.31 | 1.03 | 0.63 |
Total Current Assets | 6.53 | 11.91 | 16.14 | 85.9 | 89.15 |
Property, Plant & Equipment | 1.11 | 0.44 | 1.18 | 7.19 | 4.22 |
Long-Term Investments | 12.05 | - | - | - | - |
Other Intangible Assets | 5.29 | 5.55 | 5.58 | 65.63 | 71.64 |
Long-Term Accounts Receivable | 0.2 | - | - | - | - |
Other Long-Term Assets | 0.17 | 0.15 | 0.15 | 0.15 | 16.17 |
Total Assets | 25.35 | 18.04 | 23.05 | 158.87 | 181.19 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.73 | 1.17 | 3.28 | 4.23 | 11.66 |
Accrued Expenses | 9.8 | 10.66 | 12.68 | 64.59 | 50.64 |
Current Portion of Long-Term Debt | - | - | - | 115.22 | - |
Current Portion of Leases | 0.17 | 0.35 | 0.72 | 1.03 | 1.62 |
Other Current Liabilities | 8.52 | 10.04 | 3.31 | 12.39 | 17.55 |
Total Current Liabilities | 19.22 | 22.22 | 19.98 | 197.45 | 81.47 |
Long-Term Debt | - | - | - | - | 83.62 |
Long-Term Leases | 0.9 | 0 | 0.46 | 6.44 | 2.57 |
Other Long-Term Liabilities | 0.96 | 0.5 | 0.54 | 3.37 | 4.65 |
Total Liabilities | 21.08 | 22.73 | 20.98 | 207.27 | 172.31 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 147.64 | 35.04 | 21.44 | 2.84 | 1.5 |
Additional Paid-In Capital | 270.38 | 375.08 | 388.36 | 382.63 | 375.25 |
Retained Earnings | -413.76 | -414.8 | -407.74 | -433.86 | -367.87 |
Shareholders' Equity | 4.27 | -4.68 | 2.07 | -48.4 | 8.88 |
Total Liabilities & Equity | 25.35 | 18.04 | 23.05 | 158.87 | 181.19 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.07 | 0.36 | 1.17 | 122.69 | 87.81 |
Net Cash (Debt) | 2.9 | 4.26 | 4.4 | -102.71 | -49.81 |
Net Cash Growth | -31.92% | -3.07% | - | - | - |
Net Cash Per Share | 0.92 | 3.46 | 16.96 | -1666.53 | -1070.52 |
Filing Date Shares Outstanding | 5.09 | 1.29 | 0.79 | 0.09 | 0.05 |
Total Common Shares Outstanding | 5.09 | 1.29 | 0.79 | 0.09 | 0.05 |
Working Capital | -12.69 | -10.31 | -3.84 | -111.55 | 7.68 |
Book Value Per Share | 0.84 | -3.63 | 2.63 | -519.34 | 168.46 |
Tangible Book Value | -1.02 | -10.23 | -3.51 | -114.03 | -62.77 |
Tangible Book Value Per Share | -0.20 | -7.93 | -4.46 | -1223.51 | -1191.42 |
Machinery | 1.07 | 1.07 | 1.06 | 1.2 | 1.02 |
Leasehold Improvements | 0.38 | 0.38 | 0.38 | 0.38 | 0.36 |